The ongoing COVID19 pandemic has made it abundantly clear that infectious diseases due to pathogenic viruses with RNA genomes represents a global public health problem. Mortality and morbidity due to known RNA viruses are high and the problem is compounded due to the appearance of new viruses due to animal-human conflicts. RNA viruses such as SARS-CoV-2, Influenza, Japanese Encephalitis Virus, Dengue virus, Chikungunya virus and HIV may cause death or result in long-term sequelae in recovered patients. A number of laboratories in different parts of the world are engaged in research to identify critical intervention points in the life cycle of these viruses and exploit this knowledge to develop effective therapeutic and prophylactic strategies. To encourage a productive discussion and to disseminate knowledge about new advances in this area, we have organized, with support from the IUBMB, a focused meeting on the Biochemistry & Molecular Biology of RNA viruses.
Regional Centre for Biotechnology (RCB) is an academic institution established by the Department of Biotechnology, Govt. of India with regional and global partnerships synergizing with the programmes of UNESCO as a Category II Centre. The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines in biotechnology. A major aim of the institution is to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology in a globally competitive research milieu. RCB is an integral founding component of the NCR Biotech Science Cluster, a large academic research campus located in the National Capital Region of India adjacent to New Delhi. In 2016, RCB was recognised as an Institution of National Importance by the Parliament of India.
For more information, please visit: www.rcb.res.in or contact email@example.com